Private Equity

Updated:

Newton Biocapital Partners

Newton Biocapital Partners is a private equity based in Brussels, founded 2017; the Altss profile covers its classification, headquarters, registration, AUM...

Newton Biocapital Partners logo

Newton Biocapital Partners

Our mission is to mature innovation and support the growth of our portfolio companies to create value for patients, society, local ecosystems, and…

General information

Firm type

Private Equity

Year founded

2017

AUM

Undisclosed

Location

Region

Europe

Country

Belgium

City

Brussels

Corporate office

Avenue de Tervueren 273, 1150 Brussels, Belgium

Additional offices

Tokyo, Japan

Principals

Alain Parthoens

Chief Executive Officer

Sadashi Suzuki

Japan Representative

Guy Heynen

Chief Medical and Regulatory Officer

Michihiko Wada

Chief Regulatory and Development Officer

Danny Gonnissen

Chief Operating Officer

Pierre Detrixhe

Venture Director

Tomoko Asaoka

Scientific Director

Dario Padovani

Chief Financial Officer

Daisuke Morishita

Venture Partner

Goro Takeda

Founder

Sector focus

Digital HealthMedical DevicesDNA/RNA TherapeuticsOncologyNeurological DiseasesMetabolic DiseasesAutoimmune DiseasesGenetic DiseasesAntibody TherapeuticsSmall Molecules

Frequently asked questions

What is Newton Biocapital Partners?

Newton Biocapital Partners is a private equity headquartered in Brussels, Belgium.

When was Newton Biocapital Partners founded?

Newton Biocapital Partners was founded in 2017.

Where is Newton Biocapital Partners headquartered?

Newton Biocapital Partners is headquartered in Brussels, Belgium, in the Europe region.

What is Newton Biocapital Partners's assets under management?

Newton Biocapital Partners reports approximately Undisclosed in assets under management, as tracked by Altss.

What does Altss track for Newton Biocapital Partners?

Altss maintains an OSINT-verified profile of Newton Biocapital Partners covering investment focus (ESG policy, ticket size, target IRR, currency preference, regional focuses, industry focuses, technological focuses), team (service providers and advisors), deals (company deals and fund commitments), and network (associations and event participation). Detailed values are available to Altss subscribers.

What is Newton Biocapital Partners's website?

Newton Biocapital Partners's public website is www.newtonbiocapital.com. Verified contact details for principals and decision-makers are available to Altss subscribers.

What type of firm is Newton Biocapital Partners?

Newton Biocapital Partners is classified by Altss as a Private Equity, operating from Belgium within the Europe region.

How does Altss source intelligence on Newton Biocapital Partners?

Altss combines OSINT (open-source intelligence) with regulatory filings, public disclosures, and licensed data partners. Source provenance is tracked to support compliance-ready research workflows.

When was Newton Biocapital Partners's Altss profile last updated?

Newton Biocapital Partners's profile on Altss was last refreshed on June 3, 2026. Continuous updates are applied as new public information is verified.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Brussels Private Equity profiles